-
Clinical Trials & Development2 months agoPDUFA reauthorization offers a chance at clinical trial reforms. Will the US take it?
The reauthorization could give Congress the opportunity to help streamline clinical trials and accelerate drug research.
-
Global Biotechnology & Pharmaceutical Markets2 months agoChina’s clinical trial boom under scrutiny after 3 deaths come to light
Two House Republicans are asking the FDA to increase oversight of China-generated clinical data after three trial deaths are reported.
Helixgate Featured2 days ago
Widespread atropine use fails to sway FDA advisors on Sydnexis data
Helixgate Featured2 days ago
At least 11 PDUFAs on FDA’s November docket
Helixgate Featured2 days ago
FDA Grants Accelerated Approval to Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) for Recurrent Respiratory Papillomatosis
Uncategorized7 months ago
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Endpoints News8 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
Uncategorized6 months ago
